NK cells, engineered to express an NKG2D-based CAR with DAP10 and CD3ζ signaling domains promoted significant delay in tumor growth compared to treatment with CAR-NK cells or antibody alone following adoptive transfer into in vivo CD73+-tumor bearing mouse xenografts. Here, NT5E is linked to neoplasm.